http://rdf.ncbi.nlm.nih.gov/pubchem/patent/CN-102018696-B
Outgoing Links
| Predicate | Object |
|---|---|
| assignee | http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_b946f8a160a77d9f664816a704364d83 |
| classificationIPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-167 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K47-32 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P25-00 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K47-18 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K47-10 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K47-04 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P29-00 |
| filingDate | 2010-11-22-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| grantDate | 2013-07-03-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| inventor | http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_00d1d74db14c6accc821d69b1185c93f http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_2da39749b96d832670ca191fce29bbe1 http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_9ceacd11386157c177046bbaf78dc5c0 http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_c66b8f1d004d6e3da562af4848b21aa4 http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_7e576d9fdcb84faeb3b6405812df60d9 http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_b8aae3e4e63b497660d30116b18732f3 http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_1cc871f3ef70847bd587612a103f9be2 http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_458dc0e4437856edc82103b7765c64a3 |
| publicationDate | 2013-07-03-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber | CN-102018696-B |
| titleOfInvention | Skin external preparation containing lidocaine or pharmaceutical salt thereof |
| abstract | The invention discloses a skin external preparation containing lidocaine or pharmaceutical salts thereof, which comprises the following components in percentage by weight: 0.5-2 percent of lidocaine or pharmaceutical salts thereof, 25-50 percent of moist-locking resin and 0.75-4 percent of penetration enhancer. The specificity combination of the lidocaine or pharmaceutical salts thereof is carried out on anions which use the moist-locking resins as gel carriers, thus greatly reducing the dosage of the bulk drug lidocaine or pharmaceutical salts thereof used in the preparation during acquisition of the same curative effect, reducing the category and the dosage of auxiliary materials simultaneously, simplifying the operation process and reducing the production cost. The skin external preparation prepared by using the method has the functions of strong drug loading rate, excellent moisture capability, ventilation property and penetrability, obvious curative effect, no sensitization and the like, and is convenient in use. |
| priorityDate | 2010-11-22-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type | http://data.epo.org/linked-data/def/patent/Publication |
Incoming Links
Total number of triples: 98.